M&A
confidence high
sentiment positive
materiality 0.75
FTC grants early termination of HSR waiting period for Catalyst-Angelini merger
CATALYST PHARMACEUTICALS, INC.
- FTC early termination of HSR Act waiting period granted June 16; Catalyst aware June 22.
- Closing still requires majority shareholder approval and other customary conditions.
- Parties expect deal to close in Q3 2026.
- Catalyst shareholders to vote on merger as detailed in definitive proxy statement filed June 8.